English
Chinese (Simplified)
French
Portuguese
Spanish
German
Spread The News
Forward to a Friend
Print This Story
Write a Comment
More Industry Headlines
GE Healthcare unveils technology for imaging metal implants First-time software can create clear images despite metal.
FDA approves radiopharmaceutical to treat advanced prostate cancer Radioactive therapeutic agent can spare healthy tissue.
Monarch Medical PET Services removes CEO Gary Moyers named interim CEO.
Will the Angelina Jolie mastectomy test change cancer screening? The actress sheds awareness on new genetic screening tool for breast cancer.
What technologies should we be using for mammography? A new study fills in the gaps in digital breast mammography.
New contrast agent could last longer than traditional dyes Researchers say they have found a cheaper, more effective dye.
New 3-D technology creates map of heart signals Used to ID hard-to-find source of atrial fibrillation.
More device giants acquire Chinese companies, report New findings highlight latest trends in the global medical device market.
X-ray visible blood sensor could test stent failure An in-the-works implantable sensor could tell docs if a stent was failing.
How will ultrasound fare against MRI for pediatric Crohn's? Researchers net grant to study new ultrasound techniques for children with Crohn's.
vRad names US Oncology exec CEO
vRad said that starting Tuesday Morgan would step in for departing CEO and president Rob Kill.
Morgan spent the last seven years as chief operating officer with US Oncology, a network of more than 1,000 cancer doctors that was bought by McKesson in 2010. During his tenure, the company's revenues doubled, growing from $1.5 billion to $3 billion, vRad said.
Before joining US Oncology, Morgan led the ambulatory surgical division of the Hospital Corporation of America, vRad said.
vRad runs a network of more than 400 radiologists and also makes workflow and image sharing and storing software. Over the past few years, it has grown quickly, having bought rival teleradiology provider Nighthawk in late 2010.
vRad's outgoing CEO Kill was with the company for five years. His LinkedIn page lists his current position as a board member on an audit committee of Uroplasty Inc., a company that makes neuromodulation products to stop incontinence.
Empty Trailers Wanted - Full Service Dealer
Top Dollar Paid for empty trailers. Call our Transportation Specialist for a Quote today -- 212-558-6600 Ext. 250 
"George is a highly experienced and talented leader who will help vRad achieve its next stage of growth," Eran Broshy, chair of vRad's board of directors, and a senior advisor with the company's primary sponsor, Providence Equity Partners, said in a statement. "We also thank Rob Kill...for his leadership in successfully transitioning vRad from a niche teleradiology provider to the strong market leader it is today."
Interested in Medical Industry News?
Subscribe to DOTmed's weekly news email and always be informed.
Click here, it takes just 30 seconds.
You Must Be Logged In To Post A CommentRegisterRegistration is Free and Easy. Enjoy the benefits of The World's Leading New & Used Medical Equipment Marketplace. Register Now! |
|
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2013 DOTmed.com, Inc.
ALL RIGHTS RESERVED
